SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
Equity - Authorised | ₹599 Cr | ₹599 Cr | ₹599 Cr | ₹599 Cr | ₹599 Cr |
Equity - Issued | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
Equity Paid Up | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹55,755 Cr | ₹47,771 Cr | ₹46,223 Cr | ₹45,025 Cr | ₹41,169 Cr |
Securities Premium | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr | ₹1,193 Cr |
Capital Reserves | ₹368 Cr | ₹368 Cr | ₹368 Cr | ₹368 Cr | ₹368 Cr |
Profit & Loss Account Balance | ₹43,610 Cr | ₹37,646 Cr | ₹36,598 Cr | ₹35,320 Cr | ₹33,330 Cr |
General Reserves | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr |
Other Reserves | ₹7,028 Cr | ₹5,008 Cr | ₹4,507 Cr | ₹4,587 Cr | ₹2,715 Cr |
Reserve excluding Revaluation Reserve | ₹55,755 Cr | ₹47,771 Cr | ₹46,223 Cr | ₹45,025 Cr | ₹41,169 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹55,995 Cr | ₹48,011 Cr | ₹46,463 Cr | ₹45,264 Cr | ₹41,409 Cr |
Minority Interest | ₹3,320 Cr | ₹3,055 Cr | ₹3,017 Cr | ₹3,860 Cr | ₹3,314 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | ₹251 Cr | ₹257 Cr | ₹109 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | ₹251 Cr | ₹257 Cr | ₹109 Cr |
Unsecured Loans | - | ₹230 Cr | ₹647 Cr | ₹1,771 Cr | ₹1,413 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | ₹230 Cr | ₹647 Cr | ₹1,771 Cr | ₹1,413 Cr |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | ₹0.37 Cr |
Deferred Tax Assets / Liabilities | ₹-3,133 Cr | ₹-2,818 Cr | ₹-3,512 Cr | ₹-3,117 Cr | ₹-2,451 Cr |
Deferred Tax Assets | ₹5,409 Cr | ₹4,431 Cr | ₹4,712 Cr | ₹4,142 Cr | ₹3,441 Cr |
Deferred Tax Liability | ₹2,277 Cr | ₹1,613 Cr | ₹1,200 Cr | ₹1,024 Cr | ₹990 Cr |
Other Long Term Liabilities | ₹1,147 Cr | ₹902 Cr | ₹772 Cr | ₹823 Cr | ₹574 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹343 Cr | ₹369 Cr | ₹327 Cr | ₹511 Cr | ₹430 Cr |
Total Non-Current Liabilities | ₹-1,643 Cr | ₹-1,316 Cr | ₹-1,515 Cr | ₹246 Cr | ₹77 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹5,682 Cr | ₹4,490 Cr | ₹3,974 Cr | ₹3,584 Cr | ₹4,148 Cr |
Sundry Creditors | ₹5,682 Cr | ₹4,490 Cr | ₹3,974 Cr | ₹3,584 Cr | ₹4,148 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹2,604 Cr | ₹2,927 Cr | ₹4,965 Cr | ₹2,535 Cr | ₹1,762 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹41 Cr | ₹29 Cr | ₹47 Cr | ₹53 Cr | ₹69 Cr |
Interest Accrued But Not Due | ₹22 Cr | ₹2.90 Cr | ₹4.71 Cr | ₹9.39 Cr | ₹38 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | ₹102 Cr | ₹93 Cr | ₹35 Cr |
Other Liabilities | ₹2,541 Cr | ₹2,895 Cr | ₹4,812 Cr | ₹2,380 Cr | ₹1,619 Cr |
Short Term Borrowings | ₹5,958 Cr | ₹469 Cr | ₹2,445 Cr | ₹5,549 Cr | ₹8,371 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹5,958 Cr | ₹469 Cr | ₹2,445 Cr | ₹5,549 Cr | ₹8,371 Cr |
Short Term Provisions | ₹5,663 Cr | ₹9,323 Cr | ₹4,762 Cr | ₹4,038 Cr | ₹3,059 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹309 Cr | ₹176 Cr | ₹179 Cr | ₹202 Cr | ₹127 Cr |
Provision for post retirement benefits | ₹470 Cr | ₹427 Cr | ₹459 Cr | ₹370 Cr | ₹428 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹4,884 Cr | ₹8,720 Cr | ₹4,124 Cr | ₹3,466 Cr | ₹2,504 Cr |
Total Current Liabilities | ₹19,906 Cr | ₹17,208 Cr | ₹16,146 Cr | ₹15,706 Cr | ₹17,340 Cr |
Total Liabilities | ₹77,579 Cr | ₹66,958 Cr | ₹64,110 Cr | ₹65,077 Cr | ₹62,139 Cr |
ASSETS | |||||
Gross Block | ₹43,455 Cr | ₹38,707 Cr | ₹35,579 Cr | ₹35,116 Cr | ₹31,687 Cr |
Less: Accumulated Depreciation | ₹19,035 Cr | ₹16,042 Cr | ₹14,026 Cr | ₹12,269 Cr | ₹9,851 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹24,420 Cr | ₹22,665 Cr | ₹21,553 Cr | ₹22,847 Cr | ₹21,837 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹963 Cr | ₹798 Cr | ₹937 Cr | ₹659 Cr | ₹911 Cr |
Non Current Investments | ₹5,457 Cr | ₹5,215 Cr | ₹6,482 Cr | ₹5,246 Cr | ₹3,952 Cr |
Long Term Investment | ₹5,457 Cr | ₹5,215 Cr | ₹6,482 Cr | ₹5,246 Cr | ₹3,952 Cr |
Quoted | ₹4,487 Cr | ₹4,243 Cr | ₹5,254 Cr | ₹4,281 Cr | ₹2,971 Cr |
Unquoted | ₹1,085 Cr | ₹1,085 Cr | ₹1,341 Cr | ₹1,077 Cr | ₹1,092 Cr |
Long Term Loans & Advances | ₹2,752 Cr | ₹2,881 Cr | ₹4,061 Cr | ₹4,104 Cr | ₹3,848 Cr |
Other Non Current Assets | ₹93 Cr | ₹46 Cr | ₹4.67 Cr | ₹5.62 Cr | ₹22 Cr |
Total Non-Current Assets | ₹37,696 Cr | ₹32,094 Cr | ₹33,668 Cr | ₹33,423 Cr | ₹31,070 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹9,373 Cr | ₹7,634 Cr | ₹3,130 Cr | ₹4,897 Cr | ₹3,951 Cr |
Quoted | ₹4,935 Cr | ₹4,032 Cr | ₹3,099 Cr | ₹4,494 Cr | ₹3,389 Cr |
Unquoted | ₹4,438 Cr | ₹3,602 Cr | ₹31 Cr | ₹404 Cr | ₹562 Cr |
Inventories | ₹10,513 Cr | ₹8,925 Cr | ₹8,997 Cr | ₹7,875 Cr | ₹7,886 Cr |
Raw Materials | ₹3,478 Cr | ₹2,914 Cr | ₹3,344 Cr | ₹2,894 Cr | ₹2,784 Cr |
Work-in Progress | ₹2,497 Cr | ₹2,058 Cr | ₹1,829 Cr | ₹1,589 Cr | ₹1,834 Cr |
Finished Goods | ₹3,451 Cr | ₹3,065 Cr | ₹2,976 Cr | ₹2,725 Cr | ₹2,443 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹131 Cr | ₹122 Cr | ₹107 Cr | ₹95 Cr | ₹102 Cr |
Other Inventory | ₹955 Cr | ₹767 Cr | ₹741 Cr | ₹573 Cr | ₹724 Cr |
Sundry Debtors | ₹11,439 Cr | ₹10,485 Cr | ₹9,061 Cr | ₹9,421 Cr | ₹8,884 Cr |
Debtors more than Six months | ₹561 Cr | ₹469 Cr | ₹341 Cr | ₹335 Cr | ₹712 Cr |
Debtors Others | ₹11,293 Cr | ₹10,492 Cr | ₹8,962 Cr | ₹9,338 Cr | ₹8,397 Cr |
Cash and Bank | ₹5,770 Cr | ₹5,033 Cr | ₹6,446 Cr | ₹6,488 Cr | ₹7,276 Cr |
Cash in hand | ₹2.14 Cr | ₹1.52 Cr | ₹1.41 Cr | ₹1.46 Cr | ₹0.92 Cr |
Balances at Bank | ₹5,759 Cr | ₹5,018 Cr | ₹6,415 Cr | ₹6,471 Cr | ₹7,198 Cr |
Other cash and bank balances | ₹9.49 Cr | ₹14 Cr | ₹29 Cr | ₹15 Cr | ₹76 Cr |
Other Current Assets | ₹746 Cr | ₹775 Cr | ₹1,319 Cr | ₹1,541 Cr | ₹1,266 Cr |
Interest accrued on Investments | ₹33 Cr | ₹10 Cr | ₹6.34 Cr | ₹12 Cr | ₹16 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹372 Cr | ₹286 Cr | ₹279 Cr | ₹186 Cr | ₹169 Cr |
Other current_assets | ₹342 Cr | ₹478 Cr | ₹1,034 Cr | ₹1,344 Cr | ₹1,080 Cr |
Short Term Loans and Advances | ₹2,022 Cr | ₹2,013 Cr | ₹1,489 Cr | ₹1,432 Cr | ₹1,806 Cr |
Advances recoverable in cash or in kind | ₹545 Cr | ₹405 Cr | ₹471 Cr | ₹429 Cr | ₹412 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹1,476 Cr | ₹1,607 Cr | ₹1,018 Cr | ₹1,003 Cr | ₹1,394 Cr |
Total Current Assets | ₹39,862 Cr | ₹34,865 Cr | ₹30,442 Cr | ₹31,654 Cr | ₹31,069 Cr |
Net Current Assets (Including Current Investments) | ₹19,956 Cr | ₹17,656 Cr | ₹14,296 Cr | ₹15,948 Cr | ₹13,730 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹77,579 Cr | ₹66,958 Cr | ₹64,110 Cr | ₹65,077 Cr | ₹62,139 Cr |
Contingent Liabilities | ₹4,061 Cr | ₹3,647 Cr | ₹4,639 Cr | ₹4,909 Cr | ₹5,031 Cr |
Total Debt | ₹6,198 Cr | ₹931 Cr | ₹3,869 Cr | ₹8,315 Cr | ₹10,514 Cr |
Book Value | 233.38 | 200.11 | 193.65 | 188.66 | 172.59 |
Adjusted Book Value | 233.38 | 200.11 | 193.65 | 188.66 | 172.59 |
Compare Balance Sheet of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹360,914.7 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics | |
MANKIND PHARMA | ₹94,869.4 Cr | 1.3% | 7% | NA | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% |
-6.5% |
55.3% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses